These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 37272198)
1. Predicting the net administered activity in Henry EC; Lopez B; Mahvash A; Thomas MA; Kappadath SC Med Phys; 2023 Nov; 50(11):7003-7015. PubMed ID: 37272198 [TBL] [Abstract][Full Text] [Related]
2. Planning dosimetry for Thomas MA; Mahvash A; Abdelsalam M; Kaseb AO; Kappadath SC Med Phys; 2020 Oct; 47(10):5333-5342. PubMed ID: 32790882 [TBL] [Abstract][Full Text] [Related]
3. Nezami N; Kokabi N; Camacho JC; Schuster DM; Xing M; Kim HS Nucl Med Biol; 2018 Apr; 59():22-28. PubMed ID: 29448165 [TBL] [Abstract][Full Text] [Related]
4. High quality imaging and dosimetry for yttrium-90 ( Duan H; Khalaf MH; Ferri V; Baratto L; Srinivas SM; Sze DY; Iagaru A Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2426-2436. PubMed ID: 33443618 [TBL] [Abstract][Full Text] [Related]
5. Calculation of lung mean dose and quantification of error for Lopez B; Mahvash A; Lam MGEH; Kappadath SC Med Phys; 2019 Sep; 46(9):3929-3940. PubMed ID: 31063600 [TBL] [Abstract][Full Text] [Related]
6. Partition Model-Based 99mTc-MAA SPECT/CT Predictive Dosimetry Compared with 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison. Gnesin S; Canetti L; Adib S; Cherbuin N; Silva Monteiro M; Bize P; Denys A; Prior JO; Baechler S; Boubaker A J Nucl Med; 2016 Nov; 57(11):1672-1678. PubMed ID: 27307346 [TBL] [Abstract][Full Text] [Related]
7. A comparison of methods for in vivo activity and absorbed dose quantification with PET/CT following yttrium-90 radioembolization. Henry EC; Mahvash A; Lopez BP; Kappadath SC Med Phys; 2024 Sep; 51(9):6034-6045. PubMed ID: 38772046 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of factors affecting tumor response and survival in patients with primary and metastatic liver cancer treated with microspheres. Demirelli S; Erkilic M; Oner AO; Budak ES; Gunduz S; Ozgur O; Bozcuk H; Sindel HT; Boz A Nucl Med Commun; 2015 Apr; 36(4):340-9. PubMed ID: 25563137 [TBL] [Abstract][Full Text] [Related]
9. Characterization of Balagopal A; Kappadath SC Med Phys; 2018 Feb; 45(2):875-883. PubMed ID: 29172243 [TBL] [Abstract][Full Text] [Related]
11. PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment Efficacy. Song YS; Paeng JC; Kim HC; Chung JW; Cheon GJ; Chung JK; Lee DS; Kang KW Medicine (Baltimore); 2015 Jun; 94(23):e945. PubMed ID: 26061323 [TBL] [Abstract][Full Text] [Related]
12. Comparison of absorbed doses to the tumoral and non-tumoral liver in HCC patients undergoing Noipinit N; Sukprakun C; Siricharoen P; Khamwan K Ann Nucl Med; 2024 Mar; 38(3):210-218. PubMed ID: 38142421 [TBL] [Abstract][Full Text] [Related]
13. Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors. Ilhan H; Goritschan A; Paprottka P; Jakobs TF; Fendler WP; Todica A; Bartenstein P; Hacker M; Haug AR J Nucl Med; 2015 Nov; 56(11):1654-60. PubMed ID: 26315830 [TBL] [Abstract][Full Text] [Related]
14. Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology. Chiesa C; Mira M; Maccauro M; Spreafico C; Romito R; Morosi C; Camerini T; Carrara M; Pellizzari S; Negri A; Aliberti G; Sposito C; Bhoori S; Facciorusso A; Civelli E; Lanocita R; Padovano B; Migliorisi M; De Nile MC; Seregni E; Marchianò A; Crippa F; Mazzaferro V Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1718-1738. PubMed ID: 26112387 [TBL] [Abstract][Full Text] [Related]
15. A deep-learning-based prediction model for the biodistribution of Plachouris D; Tzolas I; Gatos I; Papadimitroulas P; Spyridonidis T; Apostolopoulos D; Papathanasiou N; Visvikis D; Plachouri KM; Hazle JD; Kagadis GC Med Phys; 2021 Nov; 48(11):7427-7438. PubMed ID: 34628667 [TBL] [Abstract][Full Text] [Related]
16. 3D image-based dosimetry for Yttrium-90 radioembolization of hepatocellular carcinoma: Impact of imaging method on absorbed dose estimates. Brosch J; Gosewisch A; Kaiser L; Seidensticker M; Ricke J; Zellmer J; Bartenstein P; Ziegler S; Ilhan H; Todica A; Böning G Phys Med; 2020 Dec; 80():317-326. PubMed ID: 33248338 [TBL] [Abstract][Full Text] [Related]
17. Comparison of perfused volume segmentation between cone-beam CT and Martin M; Hocquelet A; Debordeaux F; Bordenave L; Blanc JF; Papadopoulos P; Lapuyade B; Trillaud H; Pinaquy JB Diagn Interv Imaging; 2021 Jan; 102(1):45-52. PubMed ID: 33032960 [TBL] [Abstract][Full Text] [Related]
18. 99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization. Wondergem M; Smits ML; Elschot M; de Jong HW; Verkooijen HM; van den Bosch MA; Nijsen JF; Lam MG J Nucl Med; 2013 Aug; 54(8):1294-301. PubMed ID: 23749996 [TBL] [Abstract][Full Text] [Related]
19. PET-CT post therapy dosimetry in radioembolization with resin Richetta E; Pasquino M; Poli M; Cutaia C; Valero C; Tabone M; Paradisi BP; Pacilio M; Pellerito RE; Stasi M Phys Med; 2019 Aug; 64():16-23. PubMed ID: 31515015 [TBL] [Abstract][Full Text] [Related]
20. Hepatopulmonary Shunt Ratio Verification Model for Transarterial Radioembolization. Yeyin N; Kesmezacar FF; Tunçman D; Demir Ö; Uslu-Beşli L; Günay O; Demir M Curr Radiopharm; 2024; 17(3):276-284. PubMed ID: 38288829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]